← Eichor
Condition: Alzheimer Disease Early Onset Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Alzheimer Disease Early Onset

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases
Phase N/A · 1 location(s) · xCures · NCT06539169MIMA Pilot Study: MIcrostructure of the Medial Temporal Lobe in Early Alzheimer's Disease
NA · 1 location(s) · Rennes University Hospital · NCT06099587Chronic Treatment of Alzheimer's Disease by Gamma Light and Sound Therapy
NA · 1 location(s) · Massachusetts Institute of Technology · NCT05655195A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by
Phase 2/Phase 3 · 37 location(s) · Washington University School of Medicine · NCT05552157A Multifocal tDCS-EEG Protocol for Improving Symptoms of Mild Cognitive Impairment and Early Dementia
NA · 1 location(s) · University of Campania Luigi Vanvitelli · NCT06668610Longitudinal Early-onset Alzheimer's Disease Study Protocol
Phase N/A · 23 location(s) · Indiana University · NCT03507257Lifestyle Interventions for the Treatment of Early Onset Alzheimer's Disease Study
NA · 1 location(s) · Indiana University · NCT05573490GnRH Therapy on Cognition in Down Syndrome
Phase 2/Phase 3 · 1 location(s) · Nelly Pitteloud · NCT04390646Neuropsychological Profiles and Musical Engagement in Parkinson's and Alzheimer's Disease
NA · 3 location(s) · University Hospital, Montpellier · NCT06688968Donepezil Versus Non-drug Treatment in Alzheimer's Disease.
Phase 3 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT04661280MECHANISMS OF NEURONAL RESILIENCE IN ALZHEIMER'S DISEASE AND ITS FOCAL VARIANTS: A PET/MR STUDY
NA · 2 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT04150198A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL628 in Participants With Earl
Phase 1 · 4 location(s) · Denali Therapeutics Inc. · NCT07328451Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study
NA · 1 location(s) · Mayo Clinic · NCT02740634A Study to Evaluate the Safety and Tolerability of ALN-APP in Patients With EOAD
Phase 1 · 8 location(s) · Alnylam Pharmaceuticals · NCT05231785NYSCF Scientific Discovery Biobank
Phase N/A · 1 location(s) · New York Stem Cell Foundation Research Institute · NCT06203106Transcranial Magnetic Stimulation to Slow Down Cognitive Decline in Alzheimer's Disease
NA · 1 location(s) · Willem de Haan · NCT07036328Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PE
Phase N/A · 26 location(s) · GAP Innovations, PBC · NCT06584357Genetic Studies of Early-onset Dementia
Phase N/A · 1 location(s) · Columbia University · NCT04906863Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of AD
Phase 1 · 2 location(s) · Butler Hospital · NCT04500847Lecanemab for Early Onset Familial Alzheimer's Disease
Phase N/A · 15 location(s) · RenJi Hospital · NCT06883019The Dampness Syndrome of Chinese Medicine Cohort Study
Phase N/A · 1 location(s) · Guangzhou University of Traditional Chinese Medicine · NCT05315895Network-based biOmarker Discovery of Neurodegenerative Diseases Using Multimodal Connectivity
NA · 1 location(s) · Rennes University Hospital · NCT06080659A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by
Phase 2/Phase 3 · 37 location(s) · Washington University School of Medicine · NCT06647498Study of ARO-MAPT-SC in Healthy Participants and Participants With Early Alzheimer's Disease
Phase 1/Phase 2 · 3 location(s) · Arrowhead Pharmaceuticals · NCT07221344
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.